💾 Data Updated: 2025 HTS Revision 30 • Last updated: November 24, 2025

3002.13.00.10 - Monoclonal antibodies

Details

FieldValue
Unit of Quantitykg
General Rate of DutyFree
Special Rate of DutyN/A
Column 2 Rate of DutyFree
Quota QuantityN/A
Additional DutiesN/A

Overview

This HTS classification, 3002.13.00.10, specifically covers monoclonal antibodies. Monoclonal antibodies are a type of protein produced in a laboratory that can bind to specific targets, such as antigens on the surface of cells. They are utilized in various therapeutic, diagnostic, and research applications due to their high specificity and potency. This sub-heading is distinct from its sibling category 3002.13.00.90, which encompasses "Other" immunological products that are unmixed and not prepared for retail sale, but do not meet the specific criteria for monoclonal antibodies.

Given that this is a leaf node in the HTS, there are no further subcategories. The classification is definitive for monoclonal antibodies meeting the criteria of being unmixed and not put up in measured doses or in forms or packings for retail sale. This means that if monoclonal antibodies are presented in bulk, unassembled, or in a raw form prior to final formulation for patient administration or consumer purchase, they would fall under this specific code. The focus remains on the inherent nature of the product as a monoclonal antibody, irrespective of its ultimate end-use, provided it has not undergone further preparation for retail.

Stay Updated

Join our newsletter to get all updates of the harmonized Tariff Schedule.